Medium materiality6/10
Truist Securities assumes Corcept Therapeutics (CORT) at Buy
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist Financial initiates CORT at Buy; target $164; posted price $117.17; price change since signal +0.79.
- Buy target $164; price $117.17; +0.79 since signal
Key facts
- 01
Target: $164
- 02
Posted price: $117.17
- 03
Analyst firm: Truist Financial
- 04
Analyst: Srikripa Devarakonda
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.